RNA-seq maps genetic, nongenetic drivers of AML
Investigators used RNA sequencing to create a new gene activity atlas that showed how normal blood cells developed. The technique.
The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Investigators used RNA sequencing to create a new gene activity atlas that showed how normal blood cells developed. The technique.
Jerald Radich and Saad Usmani discusss chronic myeloid leukemia and research funding cuts on this SOHO Insider podcast episode.
Researchers observed delayed progression to multiple myeloma (MM) in patients with smoldering MM (SMM) who were treated with single-agent daratumumab.
The European Medicines Agency (EMA) has approved an Investigational Medicinal Product Dossier (IMPD) for OT-C001.
A phase 2 study found that cladribine, idarubicin, and cytarabine (CLIA) was “effective” in treating relapsed or refractory acute myeloid.
A real-world, multicenter study supported findings from the pivotal ICARIA-MM clinical trial, showing that isatuximab, pomalidomide, and dexamethasone (IsaPd) was an.
While the US relies on centralized, commercial CAR-T manufacturing, Spain is taking a different approach. At Hospital Clínic de Barcelona,.
As SOHO continues to expand and connect with a growing global community, we remain focused on supporting hematologic oncologists through.
A CD30/CD16A bispecific antibody, AFM13, “showed encouraging preliminary safety and efficacy
Odronextamab monotherapy resulted in a 48.3% overall response rate in patients with diffuse large B-cell lymphoma (DLBCL) who had progressed.
Dr. Craddock talks life in general and about the past and future of blood cancer treatments.
Giselle Kidson-Gerber, FRACP, FRCPA, a hematologist and clinical researcher at Prince of Wales Hospital and the Royal Hospital for Women,.
The novel chimeric antigen receptor (CAR) T-cell therapy talicabtagene autoleucel induced durable responses in an Indian population with relapsed or.
Benefits of membership include:
The Career Center provides SOHO members with the ability to find jobs in the field of Hematologic Oncology along with a variety of career advice. Select the 'Career Center' button to explore new job opportunities and career information.
The Career Center Allows SOHO Members to:
To access the SOHO Career Center click the following link.